Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2009-09-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于下属公司被认定为高新技术企业的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (547 characters) from a company's board about a subsidiary being recognized as a high-tech enterprise by government authorities. It contains no financial statements, no regulatory certifications, no voting results, no management changes, no earnings data, and no mention of any report publication. It is an official company announcement about a status recognition that affects tax treatment and potentially company performance. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2009-09-19 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock trading fluctuations for the company 中源协和干细胞生物工程股份公司. It discusses stock price limits being hit on specific dates, inquiries made to controlling shareholders and management, and confirms no undisclosed material information exists. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The content is a regulatory disclosure about stock price movements and company statements to clarify the situation. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2009-09-02 Chinese
关于和解协议执行进展情况公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress and completion of a settlement agreement execution between the company and another party. It details legal and procedural updates such as court case withdrawals, approvals from the stock exchange, and payment receipt. There is no financial data, no report attached or referenced as being published, and no indication of a meeting or voting results. The content is primarily a regulatory update on legal and settlement matters. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2009-09-02 Chinese
2009年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2009 年半年度报告摘要" which translates to "2009 Semi-Annual Report Summary." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements for the first half of 2009, shareholder information, and management commentary. The report includes substantive financial data and analysis for a period shorter than a full fiscal year (January to June 2009). It is not a brief announcement or a certification but a comprehensive interim financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2009
2009-08-31 Chinese
2009年半年度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled as a '2009 年半年度报告' which translates to '2009 Semi-Annual Report'. It contains detailed financial data including balance sheets, profit and loss statements, and management discussion and analysis for the first half of 2009. The document includes comprehensive financial figures, operational analysis, shareholder information, governance details, and other substantive financial and business information. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of unaudited financial statements and detailed management commentary confirms it is an Interim / Quarterly Report rather than an Annual Report or Earnings Release. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2009
2009-08-31 Chinese
有限售条件的流通股上市公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the listing of restricted tradable shares (有限售条件的流通股上市公告) of the company ST 中源 (stock code 600645). It includes information about the share reform plan, shareholder commitments, changes in shareholding, and the approval and verification by the sponsoring institution (东海证券有限责任公司). The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about the listing of restricted shares following a share reform, including detailed shareholding changes and compliance confirmations. This type of document fits best under the category of Regulatory Filings (RNS), as it is a formal regulatory announcement that does not fall into other specific categories such as capital changes (SHA) or share issue announcements, since it focuses on the listing of restricted shares post-reform and includes verification opinions from the sponsor. The document length and detail also support it being a full regulatory filing rather than a brief announcement or a report publication announcement.
2009-08-20 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.